Navigation Links
World Health Day Emphasis on Antimicrobial Resistance Brings Much-Needed Awareness to Alarming Issue
Date:4/7/2011

FRANKLIN LAKES, N.J., April 7, 2011 /PRNewswire/ -- Antimicrobial resistance – also known as drug resistance – is a growing problem that increasingly threatens the health of populations worldwide. Today, World Health Day 2011, the World Health Organization (WHO) is calling on governments and stakeholders to implement the policies and practices needed to prevent and counter the emergence of highly resistant microorganisms. BD (Becton, Dickinson and Company), a leading global medical technology company, applauds the WHO's focus on this issue and is committed to helping fight the problem.

"The continued growth of drug resistance worldwide is unsettling," said Vincent A. Forlenza, BD President and Chief Operating Officer.  "Combating it effectively will require a collaborative, multi-pronged effort from governments, the healthcare community, industry, non-governmental organizations and patient advocacy groups.  We commend the WHO for taking the lead in raising awareness of this important issue on World Health Day and stand ready to apply our technologies and expertise to help address it."

Greater attention to antibiotic stewardship and infection prevention protocols will help curb the growing impact of resistance. Through collaborations, advocacy and technology, BD is dedicated to enhancing antibiotic stewardship worldwide.  Highlights include:

  • Serving as a strategic partner to the Association for Professionals in Infection Control and Epidemiology (APIC).  In this collaboration, BD helps APIC advance its mission by supporting educational programs and initiatives to benefit the infection prevention community.
  • Collaborating with the Foundation for Innovative New Diagnostics to ensure access to improved tuberculosis (TB) diagnostics in resource-limited settings highly burdened by drug-resistant TB.  Faster, accurate diagnosis of TB reduces the time spent on inappropriate and ineffective patient treatment, which can lead to further drug resistance. 

About Antimicrobial Resistance

Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective. When the microorganisms become resistant to most antimicrobials they are often referred to as "superbugs." This is a major concern because a resistant infection may kill, spread to others, and impose huge costs to individuals and society.  For more information, visit www.who.int.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Alyssa Zeff
Public Relations
+1 (201) 847-4358 (office)
+1 (917) 273-3685 (mobile)
Alyssa_Zeff@bd.com


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
Breaking Medicine Technology:
(Date:10/13/2017)... Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD ... dose required and providing a CBD form that can be easily incorporated into liquid ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
Breaking Medicine News(10 mins):